OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2344-2352
Closed Access | Times Cited: 141

Showing 26-50 of 141 citing articles:

Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy
Dávid Dóra, Syeda Mahak Zahra Bokhari, Kenan Aloss, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2769-2769
Open Access | Times Cited: 24

Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 24

The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23

Microbiome influencers of checkpoint blockade–associated toxicity
Yinghong Wang, Robert R. Jenq, Jennifer A. Wargo, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 3
Open Access | Times Cited: 22

Microbiome bacterial influencers of host immunity and response to immunotherapy
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14

Interactions between diet and gut microbiota in cancer
Geicho Nakatsu, Natalia Andreeva, M. Macdonald, et al.
Nature Microbiology (2024) Vol. 9, Iss. 7, pp. 1644-1654
Closed Access | Times Cited: 10

Gut microbiome and immune checkpoint inhibitor toxicity
Rik J. Verheijden, Mick J M van Eijs, Fernanda L. Paganelli, et al.
European Journal of Cancer (2025) Vol. 216, pp. 115221-115221
Closed Access | Times Cited: 1

Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
D.Y. Luo, Jing Zhou, Shuiliang Ruan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Puspendu Sardar, Benjamin S. Beresford-Jones, Wangmingyu Xia, et al.
Nature Microbiology (2025) Vol. 10, Iss. 3, pp. 795-807
Open Access | Times Cited: 1

Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study
Chuan Zeng, Chaolong Zhang, Chunming He, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 17

Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment
Anne Knisely, Yongwoo David Seo, Jennifer A. Wargo, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 777-777
Open Access | Times Cited: 15

Fecal Microbiota Transplantation as a Cancer Therapeutic
Ronen Stoff, Yochai Wolf, Ben Boursi
The Cancer Journal (2023) Vol. 29, Iss. 2, pp. 102-108
Closed Access | Times Cited: 15

Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases
Jian Tan, Jemma Taitz, Ralph Nanan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15256-15256
Open Access | Times Cited: 15

The Role of Artificial Intelligence in Deciphering Diet–Disease Relationships: Case Studies
Yotam Cohen, Rafael Valdés‐Mas, Eran Elinav
Annual Review of Nutrition (2023) Vol. 43, Iss. 1, pp. 225-250
Open Access | Times Cited: 14

Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application
Yu-Pei Zhuang, Hongli Zhou, Haibin Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115040-115040
Open Access | Times Cited: 14

Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities
Rachel Goodman, Seungyeon Jung, Justin M. Balko, et al.
Immunological Reviews (2023) Vol. 318, Iss. 1, pp. 157-166
Open Access | Times Cited: 14

Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma
Russell G. Witt, Samuel Cass, Tiffaney Tran, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 10, pp. 1076-1076
Open Access | Times Cited: 13

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
Jiexi Yan, Lu Yang, Qingmiao Ren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

The Relationship Between the Modulation of Intestinal Microbiota and the Response to Immunotherapy in Patients with Cancer
Laura Radoš, Marin Golčić, Ivana Mikolašević
Biomedicines (2025) Vol. 13, Iss. 1, pp. 96-96
Open Access

The role of microbiome in CAR-T cell therapy
Reham Abdel‐Wahab, Travis Kerr, Daniel J. McGrail, et al.
International review of cell and molecular biology (2025)
Closed Access

Rethinking the rise of early onset gastrointestinal cancers: a call to action
Benjamin A. Weinberg, Caitlin C. Murphy, David R. Freyer, et al.
JNCI Cancer Spectrum (2025) Vol. 9, Iss. 1
Open Access

Bacteroidetes
Chunhua Chen, Qiqiong Li, Qixing Nie
Elsevier eBooks (2025), pp. 285-306
Closed Access

Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Maruhen Amir Datsch Silveira, Richard R. Rodrigues, Giorgio Trinchieri
Gastroenterology Clinics of North America (2025)
Closed Access

Scroll to top